関節拘縮症の世界市場レポート 2025年

関節拘縮症市場規模は、今後数年間で力強い成長が見込まれます。2029年には12億2,000万米ドルに成長し、CAGRは5.5%となります。予測期間における成長の原動力は、高齢者人口の拡大、疼痛治療薬の採用率の上昇、スポーツ傷害の増加、変形性関節症の有病率の上昇、同疾患のリスクを抱える人口の増加であると予測されます。この期間の主な動向としては、医療技術の進歩、遺伝子研究の革新、治療法の技術的進歩、非外科的治療法の開発、生物学的製剤や幹細胞治療の進歩などが挙げられます。

先天性疾患の有病率の増加は、今後数年間の関節拘縮症市場の成長を牽引すると予想されます。先天性障害とは、構造的または機能的に胎児の開発中に発生し、出生時に存在する異常です。先天性障害の有病率上昇には、出生前診断の進歩、環境暴露、遺伝子変異、ライフスタイルの変化など、いくつかの要因が寄与しています。関節拘縮症は、筋骨格系異常における胎動、遺伝的要因、神経筋発達の重要性を強調することで、先天性障害を理解する上で重要な役割を果たしています。例えば、2023年2月、世界保健機関（WHO）は、世界中で毎年約24万人の新生児が生後28日以内に先天性疾患で死亡していると報告しました。さらに、先天性疾患は生後1ヵ月から5歳までの間に推定17万人の子どもの死亡につながっています。その結果、先天性障害の有病率の増加が関節拘縮症市場の成長に寄与しています。

遠隔医療サービスの利用可能性の拡大は、関節拘縮症市場の成長をさらに促進すると予想されます。遠隔医療サービスは、ビデオ通話、電話、オンラインメッセージングなどのデジタルコミュニケーションツールを使用して遠隔でヘルスケアを提供するもので、患者は自宅やその他の場所からケアを受けることができます。遠隔医療サービスの増加は、その利便性、アクセシビリティ、特に遠隔地や十分なサービスを受けていない地域における患者のケアへのアクセスを改善しながら医療費を削減する可能性に起因しています。遠隔医療は、遠隔診察、早期診断、関節拘縮の継続的管理を可能にし、移動に課題がある人のための専門医療へのアクセスを改善することによって、関節拘縮症患者にとって有益です。例えば、2024年5月、Australian Digital Health Agencyは、9万5,000人以上の開業医が遠隔医療サービスを利用し、過去2年間で1,800万人の患者に1億1,820万件の遠隔医療相談を提供したと報告しました。その結果、遠隔医療サービスの利用の増加が関節拘縮症市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界関節拘縮症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の関節拘縮症市場：成長率分析
• 世界の関節拘縮症市場の実績：規模と成長, 2019-2024
• 世界の関節拘縮症市場の予測：規模と成長, 2024-2029, 2034F
• 世界関節拘縮症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の関節拘縮症市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 古典型関節拘縮症
• 遠位関節拘縮症
• 筋形成不全
• 世界の関節拘縮症市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 作業療法士
• 理学療法
• 手術
• 画像診断
• CTスキャン
• 世界の関節拘縮症市場患者の年齢別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子供
• 大人
• 高齢者
• 世界の関節拘縮症市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界の関節拘縮症市場、古典型関節拘縮症のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 複数の関節の障害
• 屈曲拘縮
• 重度の筋力低下
• プログレッシブ関節拘縮症
• 知的障害
• 世界の関節拘縮症市場遠位関節拘縮症の分類（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 四肢単独障害
• 手足の拘縮
• 遠位関節拘縮
• 常染色体優性遺伝
• 世界の関節拘縮症市場筋形成不全症の分類（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 重度の四肢拘縮
• 筋緊張低下（筋緊張の低下）
• 認知障害なし
• 対称性関節障害
• 患肢の筋肉開発不全

第7章 地域別・国別分析

• 世界の関節拘縮症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の関節拘縮症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 関節拘縮症市場：競合情勢
• 関節拘縮症市場：企業プロファイル
  • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • The Cleveland Clinic Foundation Overview, Products and Services, Strategy and Financial Analysis
  • The Johns Hopkins Health System Corporation Overview, Products and Services, Strategy and Financial Analysis
  • NYU Langone Hospitals Overview, Products and Services, Strategy and Financial Analysis
  • Seattle Children's Hospital Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Children's Hospital
• Phoenix Children's Hospital Inc.
• Children's Healthcare of Atlanta Inc.
• The Nemours Foundation
• Shriners Hospitals for Children
• Hanger Inc.
• Texas Scottish Rite Hospital for Children
• Gillette Children's Specialty Healthcare
• Paley Orthopedic & Spine Institute LLC
• Quantum Rehab a division of Pride Mobility Products Corp.
• Obi Robot Inc.
• Gammie HomeCare LLC
• Prothotic Laboratories Inc.
• SSM Health Cardinal Glennon Children's Hospital
• Arthrogryposis Multiplex Congenita Support Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 関節拘縮症市場2029：新たな機会を提供する国
• 関節拘縮症市場2029：新たな機会を提供するセグメント
• 関節拘縮症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Arthrogryposis is a group of congenital conditions marked by multiple joint contractures, leading to stiffness and restricted movement. It occurs when there is reduced fetal movement in the womb, which may be caused by neurological, muscular, or connective tissue disorders.

The main types of arthrogryposis include classic arthrogryposis, distal arthrogryposis, and amyoplasia. Classic arthrogryposis is characterized by multiple joint contractures (stiffness or fixation) present at birth, often associated with muscle weakness and limited mobility. Treatment options include occupational therapy, physical therapy, surgery, imaging diagnostics, and CT scans. The disorder can affect individuals of all ages, from children to the elderly, and treatments are available through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and other distribution methods.

The arthrogryposis market research report is one of a series of new reports from The Business Research Company that provides arthrogryposis market statistics, including the arthrogryposis industry global market size, regional shares, competitors with the arthrogryposis market share, detailed arthrogryposis market segments, market trends, and opportunities, and any further data you may need to thrive in the arthrogryposis industry. This arthrogryposis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arthrogryposis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $0.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the rising prevalence of osteoarthritis, an increase in sports-related injuries, a growing aging population, more sedentary lifestyles, and heightened awareness of osteoarthritis therapeutics.

The arthrogryposis market size is expected to see strong growth in the next few years. It will grow to $1.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period is expected to be driven by the expanding geriatric population, a higher adoption of pain medications, an increasing number of sports injuries, the rising prevalence of osteoarthritis, and a growing population at risk for the condition. Key trends during this period include advancements in medical technology, innovations in genetic research, technological progress in treatment options, the development of non-surgical treatments, and advancements in biologics and stem cell therapies.

The increasing prevalence of congenital disorders is expected to drive the growth of the arthrogryposis market in the coming years. Congenital disorders are abnormalities that occur during fetal development, either structurally or functionally, and are present at birth. Several factors contribute to the rising prevalence of congenital disorders, including advancements in prenatal diagnostics, environmental exposures, genetic mutations, and lifestyle changes. Arthrogryposis plays a crucial role in understanding congenital disorders by emphasizing the importance of fetal movement, genetic factors, and neuromuscular development in musculoskeletal abnormalities. For example, in February 2023, the World Health Organization reported that approximately 240,000 newborns worldwide die from congenital disorders within the first 28 days of life each year. Additionally, congenital conditions lead to an estimated 170,000 child deaths between the ages of 1 month and 5 years. As a result, the increasing prevalence of congenital disorders is contributing to the growth of the arthrogryposis market.

The growing availability of telehealth services is expected to further drive the growth of the arthrogryposis market. Telehealth services use digital communication tools such as video calls, phone calls, and online messaging to provide healthcare remotely, allowing patients to receive care from home or other locations. The rise in telehealth services can be attributed to their convenience, accessibility, and potential to reduce healthcare costs while improving patient access to care, particularly in remote or underserved areas. Telehealth is beneficial for arthrogryposis patients by enabling remote consultations, early diagnosis, and ongoing management of joint contractures, improving access to specialized care for individuals with mobility challenges. For instance, in May 2024, the Australian Digital Health Agency reported that over 95,000 practitioners had utilized telehealth services, offering 118.2 million telehealth consultations to 18 million patients over the past two years. Consequently, the increasing use of telehealth services is driving the growth of the arthrogryposis market.

Companies in the arthrogryposis market are also focusing on advancing surgical techniques, such as carpal wedge osteotomy, to improve joint mobility and reduce contractures, ultimately enhancing patients' functional outcomes and quality of life. Carpal wedge osteotomy is a surgical procedure that involves removing a wedge-shaped section of bone from the wrist to correct joint deformities and improve hand function in patients with conditions such as arthrogryposis. For example, in November 2022, Akron Children's Hospital, a US-based pediatric care hospital, developed a new procedure combining carpal wedge osteotomy with flexor-pronator slide to improve joint mobility in patients with this rare condition, which is characterized by stiff or contracted joints.

Major players in the arthrogryposis market are Hitachi Ltd., The Cleveland Clinic Foundation, The Johns Hopkins Health System Corporation, NYU Langone Hospitals, Seattle Children's Hospital, Boston Children's Hospital, Phoenix Children's Hospital Inc., Children's Healthcare of Atlanta Inc., The Nemours Foundation, Shriners Hospitals for Children, Hanger Inc., Texas Scottish Rite Hospital for Children, Gillette Children's Specialty Healthcare, Paley Orthopedic & Spine Institute LLC, Quantum Rehab a division of Pride Mobility Products Corp., Obi Robot Inc., Gammie HomeCare LLC, Prothotic Laboratories Inc., SSM Health Cardinal Glennon Children's Hospital, and Arthrogryposis Multiplex Congenita Support Inc.

North America was the largest region in the arthrogryposis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arthrogryposis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arthrogryposis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arthrogryposis market consists of revenues earned by entities by providing services such as medical diagnosis and consultation, surgical interventions, orthotic services, and pediatric care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arthrogryposis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arthrogryposis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arthrogryposis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arthrogryposis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Classic Arthrogryposis; Distal Arthrogryposis; Amyoplasia
• 2) By Treatment Type: Occupational Therapists; Physical Therapy; Surgery; Imaging Diagnostics; CT Scan
• 3) By Patient Age: Children; Adults; Elderly
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Classic Arthrogryposis: Multiple Joint Involvement; Flexion Contractures; Severe Muscle Weakness; Progressive Arthrogryposis; Intellectual Impairment
• 2) By Distal Arthrogryposis: Isolated Limb Involvement; Contractures of Hands and Feet; Distal Joint Contractures; Autosomal Dominant Inheritance
• 3) By Amyoplasia: Severe Limb Contractures; Muscle Hypotonia (low muscle tone); No Cognitive Impairment; Symmetric Joint Involvement; Lack Of Muscle Development In Affected Limbs
• Companies Mentioned: Hitachi Ltd.; The Cleveland Clinic Foundation; The Johns Hopkins Health System Corporation; NYU Langone Hospitals; Seattle Children's Hospital
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Arthrogryposis Market Characteristics

3. Arthrogryposis Market Trends And Strategies

4. Arthrogryposis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Arthrogryposis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Arthrogryposis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Arthrogryposis Market Growth Rate Analysis
• 5.4. Global Arthrogryposis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Arthrogryposis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Arthrogryposis Total Addressable Market (TAM)

6. Arthrogryposis Market Segmentation

• 6.1. Global Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classic Arthrogryposis
• Distal Arthrogryposis
• Amyoplasia
• 6.2. Global Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Occupational Therapists
• Physical Therapy
• Surgery
• Imaging Diagnostics
• CT Scan
• 6.3. Global Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Elderly
• 6.4. Global Arthrogryposis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Arthrogryposis Market, Sub-Segmentation Of Classic Arthrogryposis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multiple Joint Involvement
• Flexion Contractures
• Severe Muscle Weakness
• Progressive Arthrogryposis
• Intellectual Impairment
• 6.6. Global Arthrogryposis Market, Sub-Segmentation Of Distal Arthrogryposis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolated Limb Involvement
• Contractures of Hands and Feet
• Distal Joint Contractures
• Autosomal Dominant Inheritance
• 6.7. Global Arthrogryposis Market, Sub-Segmentation Of Amyoplasia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Severe Limb Contractures
• Muscle Hypotonia (low muscle tone)
• No Cognitive Impairment
• Symmetric Joint Involvement
• Lack Of Muscle Development In Affected Limbs

7. Arthrogryposis Market Regional And Country Analysis

• 7.1. Global Arthrogryposis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Arthrogryposis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Arthrogryposis Market

• 8.1. Asia-Pacific Arthrogryposis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Arthrogryposis Market

• 9.1. China Arthrogryposis Market Overview
• 9.2. China Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Arthrogryposis Market

• 10.1. India Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Arthrogryposis Market

• 11.1. Japan Arthrogryposis Market Overview
• 11.2. Japan Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Arthrogryposis Market

• 12.1. Australia Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Arthrogryposis Market

• 13.1. Indonesia Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Arthrogryposis Market

• 14.1. South Korea Arthrogryposis Market Overview
• 14.2. South Korea Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Arthrogryposis Market

• 15.1. Western Europe Arthrogryposis Market Overview
• 15.2. Western Europe Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Arthrogryposis Market

• 16.1. UK Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Arthrogryposis Market

• 17.1. Germany Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Arthrogryposis Market

• 18.1. France Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Arthrogryposis Market

• 19.1. Italy Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Arthrogryposis Market

• 20.1. Spain Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Arthrogryposis Market

• 21.1. Eastern Europe Arthrogryposis Market Overview
• 21.2. Eastern Europe Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Arthrogryposis Market

• 22.1. Russia Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Arthrogryposis Market

• 23.1. North America Arthrogryposis Market Overview
• 23.2. North America Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Arthrogryposis Market

• 24.1. USA Arthrogryposis Market Overview
• 24.2. USA Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Arthrogryposis Market

• 25.1. Canada Arthrogryposis Market Overview
• 25.2. Canada Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Arthrogryposis Market

• 26.1. South America Arthrogryposis Market Overview
• 26.2. South America Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Arthrogryposis Market

• 27.1. Brazil Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Arthrogryposis Market

• 28.1. Middle East Arthrogryposis Market Overview
• 28.2. Middle East Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Arthrogryposis Market

• 29.1. Africa Arthrogryposis Market Overview
• 29.2. Africa Arthrogryposis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Arthrogryposis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Arthrogryposis Market, Segmentation By Patient Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Arthrogryposis Market Competitive Landscape And Company Profiles

• 30.1. Arthrogryposis Market Competitive Landscape
• 30.2. Arthrogryposis Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Cleveland Clinic Foundation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Johns Hopkins Health System Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. NYU Langone Hospitals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Seattle Children's Hospital Overview, Products and Services, Strategy and Financial Analysis

31. Arthrogryposis Market Other Major And Innovative Companies

• 31.1. Boston Children's Hospital
• 31.2. Phoenix Children's Hospital Inc.
• 31.3. Children's Healthcare of Atlanta Inc.
• 31.4. The Nemours Foundation
• 31.5. Shriners Hospitals for Children
• 31.6. Hanger Inc.
• 31.7. Texas Scottish Rite Hospital for Children
• 31.8. Gillette Children's Specialty Healthcare
• 31.9. Paley Orthopedic & Spine Institute LLC
• 31.10. Quantum Rehab a division of Pride Mobility Products Corp.
• 31.11. Obi Robot Inc.
• 31.12. Gammie HomeCare LLC
• 31.13. Prothotic Laboratories Inc.
• 31.14. SSM Health Cardinal Glennon Children's Hospital
• 31.15. Arthrogryposis Multiplex Congenita Support Inc.

32. Global Arthrogryposis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arthrogryposis Market

34. Recent Developments In The Arthrogryposis Market

35. Arthrogryposis Market High Potential Countries, Segments and Strategies

• 35.1 Arthrogryposis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Arthrogryposis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Arthrogryposis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer